Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial.

Transplant international : official journal of the European Society for Organ Transplantation - 1 Dec 2018

Oblak Manca, Mlinšek Gregor, Kandus Aljoša, Buturović-Ponikvar Jadranka, Arnol Miha

Abstract excerpt

Proteinuria after kidney transplantation is accompanied by an increased risk of graft failure. In this single-center, placebo-controlled, double-blind trial we studied whether vitamin D receptor activator paricalcitol might reduce proteinuria. Patients with urinary protein-to-creatinine ratio (UPCR) ≥20 mg/mmol despite optimization of the renin angiotensin aldosterone system (RAAS) blockade were randomly assigned...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albuminuria
Share to Angiotensin-Converting Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Density Conservation Agents

Share to Creatinine

Share to Graft Survival

Share to Kidney Function Tests

Share to Proteinuria

Share to Renal Insufficiency

Source

Identifiers

PMID: 30062716
DOI: 10.1111/tri.13323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial.PMID 30062716Read ↗

Renal Outcomes and Dosage Considerations Associated with Bisphosphonate Use: A Systematic Review of Randomized Clinical TrialsSemantic proximity Read ↗

Effectivity and Safety Profile of Tenapanor, a Sodium-Hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease, a Systematic Review of Clinical StudiesSemantic proximity Read ↗

The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: Protocol for a Systematic Review.Semantic proximity Read ↗

Evaluating the Efficacy of Finerenone in Reducing Proteinuria in Diabetic Nephropathy Patients Receiving Maximum Tolerable Doses of Dapagliflozin and TelmisartanSemantic proximity Read ↗

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studySemantic proximity Read ↗

Post-transplant proteinuria associated with everolimus: Definition of main features with proteomics.Semantic proximity Read ↗

Urinary Markers of Tubular Injury and Renal Fibrosis in Patients with Type 2 Diabetes and Different Phenotypes of Chronic Kidney DiseaseSemantic proximity Read ↗

Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy.Semantic proximity Read ↗

Questioning the kidney-protective effects of tolvaptan: a testable hypothesis to revisit the current narrativeSemantic proximity Read ↗

First and Second Morning Spot Urine Protein Measurements for the Assessment of Proteinuria: A Diagnostic Accuracy Study in Kidney Transplant RecipientsSemantic proximity Read ↗

The Effect of Mannitol Addition on Hydration in Acute Kidney Injury Event After High Dose Cisplatin Chemotherapy: An Ambispective Cohort StudySemantic proximity Read ↗

Effect of paricalcitol and GcMAF on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.